Showing results (91-100 of 175) with videos related to

Sort By:
Pageof 18
Clinical and Experimental Pharmacology & Physiology|June 1, 1996
Examination of the role of nitric oxide synthase and renal kallikrein as candidate genes for essential hypertensionL R Friend, B J Morris, P T Gaffney, et al.
The Journal of Pharmacy and Pharmacology|September 29, 1998
Optimization of sustained-release diltiazem formulations in man by use of an in-vitro/in-vivo correlationK Yu, M Gebert, S A Altaf, et al.
Drug Delivery and Translational Research|March 20, 2015
Development of a UC781 releasing polyethylene vinyl acetate vaginal ringChristopher McConville, Ian Major, David R Friend, et al.
Menopause (New York, N.Y.)|February 2, 2023
Evaluation of 28-day estradiol and progesterone vaginal rings in a phase 1 clinical pharmacokinetic studyLouise Hull, Bronwyn G A Stuckey, Kimberly Hartman, et al.
Antiviral Research|November 27, 2010
Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccinesKevin J Whaley, Justin Hanes, Robin Shattock, et al.
Biomicrofluidics|June 5, 2012
Organosilane deposition for microfluidic applicationsNick R Glass, Ricky Tjeung, Peggy Chan, et al.
Biomicrofluidics|May 7, 2015
Pulmonary monoclonal antibody delivery via a portable microfluidic nebulization platformChristina Cortez-Jugo, Aisha Qi, Anushi Rajapaksa, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 13, 2010
Microfluidic devices for bioapplicationsLeslie Y Yeo, Hsueh-Chia Chang, Peggy P Y Chan, et al.
Experimental Cell Research|February 22, 2002
Structural polarity and functional bile canaliculi in rat hepatocyte spheroidsSusan Fugett Abu-Absi, Julie R Friend, Linda K Hansen, et al.
Clinical Nephrology|May 1, 1996
Weight reduction and fluid intake in an obese and fluid noncompliant ESRD patientN K Wadhwa, R Friend, V Gaus, et al.
Pageof 18